-
-
An Auspicious Start to the Year of the Rabbit: Fosun Sees Boom in Various Businesses During the Spring Festival Golden Week
2023-01-30
During the Spring Festival Golden Week this year, benefiting from the recovery of domestic consumption, various operating indicators of the business segments like Happiness and Health of Fosun International Limited (“Fosun International” or the “Company”) (HKEX: 00656) surged, setting an auspicious start to the Year of the Rabbit.During the Spring Festiv
-
-
Fosun International’s 2021 Annual Report Wins Gold Award at the 2022 International ARC Awards
2023-01-27
On 27 January 2023, winners of the 36th International ARC Awards were announced.The2021 annual report of Fosun International Limited (“Fosun International”or the“Company”, HKEX: 00656) won Gold Award in the“Traditional Annual Report”category of the 2022 International ARC Awards. The awardcommendsFosun International’s annual report for its distinctive theme, clear business
-
-
Fosun International Wins Platinum Award at The Asset ESG Corporate Awards 2022
2023-01-26
(26 January 2023) Fosun International Limited (“Fosun International” or the “Company”) (HKEX: 00656) was informed byThe Asset, the renowned international asset management and investment magazine, that Fosun has garnered the Platinum Award at The Asset ESG Corporate Awards 2022.This year, Fosun International was accredited with the Platinum Award byThe Assetfor t
-
-
A Healthy Winter Action: Second Batch of 19,600 Bottles of Azvudine Delivered to 24 Counties; COVID-19 Prevention and Treatment Live-Streaming Training for Rural Doctors Attracted over 1 Million Views
2023-01-21
On January 16, the second stage of “A Healthy Winter Action” initiated by Fosun Foundation in conjunction with other institutions kicked off, with 19,600 bottles of Azvudine gradually shipped to the rural clinics of 24 counties across Sichuan, Chongqing, Gansu, Hainan, Yunnan, Guizhou and Jiangxi provinces. The drugs were donated together with the
-
-
Guo Guangchang: the Reunion Dinner I Missed Three Years Ago
2023-01-21
“Guangchang, Shanghai is in urgent need of anti-epidemic materials!”On Chinese New Year’s Eve three years ago, my mobile phone rang kept ringing when I was preparing the reunion dinner with my family. It was a call from a leader in Shanghai.At that time, the COVID-19 outbreak was spreading across the country at its peak. Following the call, I immediately convened an emergen
-
-
COMIRNATY® Bivalent COVID-19 Vaccine is Officially Approved as Regular Imported Vaccine by the Pharmaceutical Administration Bureau of Macao SAR
2023-01-20
(Shanghai, China, January 20, 2023) On January 20, 2023, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma” or “Group”; Stock Code: 600196.SH, 02196.HK) announced that COMIRNATY®Original/Omicron BA.4/BA.5 bivalent COVID-19 vaccine (also known as COMIRNATY® Bivalent COVID-19 Vaccine) is officially approved as a regular imported vaccine by
-
-
Henlius’ Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ES-SCLC
2023-01-17
-
-
Fosun Receives RMB12 Billion Syndicated Loan from 8 Banks to Jointly Promote Development of the Private Economy
2023-01-16
On 16 January 2023, Shanghai Fosun High Technology (Group) Co., Ltd. (“Fosun High Technology”) and eight domestic banks held a syndicated loan signing ceremony at the Bund Finance Center, Shanghai. According to the agreement, Industrial and Commercial Bank of China, Agricultural Bank of China, Bank of China, China Construction Bank, an
-
-
Fosun International Receives Four Awards from Corporate Governance Asia
2023-01-11
Chen Qiyu and Xu Xiaoliang, Executive Directors and Co-CEOs of Fosun International win Asia’s Best CEO from Corporate Governance AsiaFosun International also receives Asia’s Best CSR and Best Corporate Communications AwardsOn 11 January 2023, the Corporate Governance Asia magazine presented the 12th Asian Excellence Award. Chen Qiyu and Xu Xiaoliang, Execu